Table 4.
Comparison between fluorometholone, prednisolone, and loteprednol groups
| Parameter (Mean±SD) | Fluorometholone | Prednisolone | Loteprednol | P |
|---|---|---|---|---|
| Age | 30.2±6.02 | 24.6±1.52 | 26.5±3.32 | 0.18 |
| Day of presentation after surgery | 3.4±1.14 | 1.8±1.1 | 4±2 | 0.084 |
| UCVA at presentation | 0.42±0.13 | 0.5±0.16 | 0.43±0.13 | 0.628 |
| PHVA at presentation | 0.2±0.12 | 0.18±0.15 | 0.18±0.1 | 0.962 |
| UCVA at last visit | 0.05±0.06 | 0.14±0.09 | 0.05±0.06 | 0.173 |
| BCVA at last visit | 0.05±0.06 | 0.08±0.08 | 0.05±0.06 | 0.809 |
| Time for resolution (days) | 6.75±1.5 | 12±5.57 | 8.75±5.56 | 0.303 |
| UCVA improvement (%) | 91.67±11.79 | 72.48±20.17 | 87.5±15.96 | 0.261 |
UCVA=Uncorrected visual acuity, PHVA=Pinhole visual acuity, BCVA=Best-corrected visual acuity